showed a trendP = 0.081
Thickness of the intimae-media right carotid artery showed a trend of higher values in diabetic patients (0.9 ± 0.29 mm in GD and 0.76 ± 0.216, P = 0.081), other indexes of carotid thickness were similar between groups.
Thickness of the intimae-media right carotid artery showed a trend of higher values in diabetic patients (0.9 ± 0.29 mm in GD and 0.76 ± 0.216, P = 0.081), other indexes of carotid thickness were similar between groups.
Pairwise comparison for CS trials within individual days showed a trend towards a slower CRonset time for Fc mice when compared to WT mice on D25 ( p = 0.081, 95% CI = [−7.85, 176.8], Figure 1 C).
tRNAGlyTCC-1 dKO mice showed a trend-level increase in the time spent immobile compared with WT control mice ( n = 14 M WT, 13 F WT/16 M KO, 13 F KO; 2-way ANOVA, genotype: F 1,52 = 3.170, p = .081; sex: F 1,52 = 1.235, p = .271; interaction: F 1,52 = 0.967, p = .330).
Similarly, in patients with seronegative status, baseline antibody reactivity showed a trend at 9 months toward association with SDAI non-remission (OR (95% CI): 4.44 (0.84 to 34.95), p=0.081 for multivariable analysis) ( table 7 ).
Similarly, although higher CA-125 levels showed a trend toward an association, this relationship did not reach statistical significance in the multivariable model (OR = 1.06, 95% CI: 0.99–1.14; P = .081) (Table 4 ). 4.
VC %LLN was independently associated with in-hospital mortality (−9.13, p = 0.044) and showed a trend for ARDS (−7.04, p = 0.081).
In support of these data, there were no differences in mitochondrial protein content (CII, CIII, CIV, CV; Figure 2b , p > 0.10), PGC1α, or SIRT1, though the ratio of pAMPK: tAMPK showed a trend towards a reduction with HFD feeding (Figure 2b , p = 0.081).
Analysis of genetic inheritance models showed a trend consistent with a dominant model for the effect of the T allele on the risk of developing JLSd ( p = 0.081; OR = 1.73; 95% CI: 0.94–3.18) ( Figure 3 ).
However, the percent change in anteroposterior (AP) diameter showed a trend towards statistical significance: -3.86% [-26.5%, 18.7%] for the surgical side versus 0.32% [-20.9%, 21.5%] for the contralateral side (p = 0.081).
Sepsis showed a trend toward increased odds of intubation (OR 2.59; 95% CI 0.89–7.52; p = 0.081), as presented in Table 6 .
In the controls, only the comparison between baseline and Flash showed a trend for a lower initial amplitude ( p = 0.081, FDR-corr.).
The percentages of Foxp3-positive cells and CCR4-positive cells showed a trend toward positive correlation (Spearman’s ρ = 0.318 and P = .081 when excluding outlier results) ( Figure 3E ), and Foxp3-positive Tregs were more abundant in HAVCR2 WT SPTCLs ( P = .033) ( Figure 3G ).
High levels of glycoalbumin showed a trend towards association with an increased risk of colorectal cancer in men (OR = 2.39, p=0.081 for the highest tertile).
Lower eGFRcys was associated with higher fat mass (Spearman correlation of -0.26, P = 0.023), and a higher eGFRcre/eGFRcys ratio showed a trend towards lower lean mass (Spearman correlation of -0.20, P = 0.081).
However, the experimental group showed a trend for less ointment use than the control group ( p = 0.081).
Accordingly, the results of the open field test showed a trend toward decreased anxiety ( Figure 2B , young: p = 0.081, aged: p = 0.292) and anxiety was significantly reduced in the young MIM KO cohort in the light/dark test [young: F (1,42) = 14.20, p = 0.001, aged: p = 0.812].
For DLCO% decline, no significant differences were observed ( p = 0.43); however, nfHP patients showed a trend towards an immediate DLCO% increase of 3.38% after corticoid treatment initiation ( p = 0.081).
A correlation between WHO/ISUP grade groups and PSMA %neg did not reach significance but showed a trend towards lower grade groups associated with higher percentages of PSMA negative areas ( p = 0.081, Kruskal–Wallis test).
When analyzing the mean signal intensity of TSPO immunoreactivity, the hippocampus showed a trend towards an increase ( p = 0.081, t = 2.513, df = 3.208) (Fig. 3 C).
Participants with higher baseline B cell levels showed a trend to be more likely to report no AMS compared to the mild and moderate–severe AMS groups (Figure S8 , main effect of location: F (2, 22.6) = 11.3, p = 0.081).
only showed a trend of worse median OS of those with p53 genomic deletions versus those with wild type TP53 alleles (2.1 versus 3.1 years; p = 0.081) [ 25 ].
However, the effect of gender was attenuated; although males showed a trend towards lower odds (OR = 0.482), it did not reach statistical significance ( p = 0.081), suggesting a less definitive role of gender in horizontal canal BPPV.
In addition, peptide B7 showed a trend to decrease the secretion of pro-inflammatory IFN-γ ( p = 0.081) and increase chemoattractant CCL-2 ( p = 0.076), while peptide B12 displayed a trend to increase the secretion of IL-23 ( p = 0.125).
The myosteatotic phenotype showed a trend toward increased mortality risk that did not reach statistical significance after multivariable adjustment (HR 1.41, 95% CI 0.95–2.09, p = 0.081).
Although elevated LDH showed a trend for predicting disease recurrence, it was not significant ( p = 0.081; Figure 6A ).